Nevertheless, our results show that MDD should not be treated with repurposing anti-inflammatory drugs (e.g., Cox-2 inhibitors) and antioxidant supplements (e.g., curcumin), but rather should boost Treg functions and target CD40L or CD71 and IL-16 to attenuate T cell activation. This evidence concerns the gene CD40LG and major depressive disorder.